IntraLase prepares for $92 million IPO

Irvine, CA-In anticipation of the initial public offering (IPO) of its common stock, IntraLase Corp. has filed a registration statement with the Securities and Exchange Commission.

Related Videos

Related Content

Outlook Therapeutics requests Type A meeting with FDA

September 29th 2023

EyePod: Transforming the MIGS pipeline into clinical reality

September 26th 2023

BLOG: MicroPulse TLT for patients who struggle with drops

September 29th 2023

EyePod: Week in Review - September 17, 2023

September 23rd 2023

Kriya announces exclusive license, collaboration, agreement with Everads to advance gene therapies for diseases in ophthalmology, Including GA

September 28th 2023

Treating anisometropic amblyopia in Argentinian patients with a dichoptic digital platform

September 28th 2023

Outlook Therapeutics requests Type A meeting with FDA

September 29th 2023

EyePod: Transforming the MIGS pipeline into clinical reality

September 26th 2023

BLOG: MicroPulse TLT for patients who struggle with drops

September 29th 2023

EyePod: Week in Review - September 17, 2023

September 23rd 2023

Kriya announces exclusive license, collaboration, agreement with Everads to advance gene therapies for diseases in ophthalmology, Including GA

September 28th 2023

Treating anisometropic amblyopia in Argentinian patients with a dichoptic digital platform

September 28th 2023

Outlook Therapeutics requests Type A meeting with FDA

September 29th 2023

EyePod: Transforming the MIGS pipeline into clinical reality

September 26th 2023

BLOG: MicroPulse TLT for patients who struggle with drops

September 29th 2023

EyePod: Week in Review - September 17, 2023

September 23rd 2023

Kriya announces exclusive license, collaboration, agreement with Everads to advance gene therapies for diseases in ophthalmology, Including GA

September 28th 2023

Treating anisometropic amblyopia in Argentinian patients with a dichoptic digital platform

September 28th 2023

Related Content

Advertisement

---

Outlook Therapeutics requests Type A meeting with FDA

Article

---

EyePod: Transforming the MIGS pipeline into clinical reality

Podcast

---

BLOG: MicroPulse TLT for patients who struggle with drops

Article

---

EyePod: Week in Review - September 17, 2023

Podcast

---

Kriya announces exclusive license, collaboration, agreement with Everads to advance gene therapies for diseases in ophthalmology, Including GA

Article

---

Treating anisometropic amblyopia in Argentinian patients with a dichoptic digital platform

Article